Yahoo
NasdaqCM - BOATS Real Time Price USD

Microbot Medical Inc. (MBOT)

1.0900 -0.0300 (-2.68%)
At close: October 30 at 4:00:01 PM EDT
1.1000 +0.0100 (+0.92%)
Overnight: 12:03:05 AM EST
Trade MBOT on Coinbase
Chart Range Bar
Loading chart for MBOT
Chart does not reflect overnight price.
  • Previous Close 1.1200
  • Open 1.1100
  • Bid 1.0700 x 300
  • Ask 1.0800 x 200
  • Day's Range 1.0400 - 1.1100
  • 52 Week Range 0.9300 - 2.8600
  • Volume 1,334,951
  • Avg. Volume 716,743
  • Market Cap (intraday) 73.202M
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 5.38
  • Zacks Rating Bearish

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

microbotmedical.com

43

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MBOT
45.50%
S&P 500 (^GSPC)
10.73%

1-Year Return

MBOT
49.54%
S&P 500 (^GSPC)
11.11%

3-Year Return

MBOT
3.54%
S&P 500 (^GSPC)
81.91%

5-Year Return

MBOT
84.92%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 241k
Earnings -5.63M
Profit Margin -2,334.85%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-4M
-2M
0
-3000.0%
-2000.0%
-1000.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

2.50
5.38 Average
1.0900 Current
12.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/23/2026
Analyst Citizens
Rating Action Initiated
Rating Market Outperform
Price Action Announces
Price Target 2.5

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    73.21M

  • Enterprise Value

    6.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    196.79

  • Price/Book (mrq)

    1.06

  • Enterprise Value/Revenue

    19.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.72%

  • Return on Equity (ttm)

    -32.91%

  • Revenue (ttm)

    346k

  • Net Income Avi to Common (ttm)

    -16.34M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    67.37M

  • Total Debt/Equity (mrq)

    1.27%

  • Levered Free Cash Flow (ttm)

    -14.24M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.0900 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: